From a residue standpoint, the answer is yes, but the other part of it is tracking, with detail, what drugs are being used, for example, in a long-term care facility, so that we know what's coming out. If we can't link antimicrobial resistance data on pathogens and bacteria to whether it's residues or use in those populations, then it's hard to understand what's driving resistance levels.
